"Advances in the Transdermal Drug Delivery Market" Published

Nov. 27, 2010 - PRLog -- The market for drugs delivered transdermally was valued at $5.6bn in 2009 with the majority of these sales being accrued by products utilizing first generation patch technologies. Innovative technologies that are able to deliver drugs with a broader spectrum of characteristics are poised to revolutionize the transdermal drug delivery market and drive significant growth. This report analyses the current state of the transdermal drug market, evaluating its therapeutic uses and the positioning of leading players. The pipeline of transdermal drugs is assessed by therapeutic indication and innovative delivery technologies are discussed at length and benchmarked against one another.

This report analyses the current state of the transdermal drug market, evaluating its therapeutic uses and the positioning of leading players. The pipeline of transdermal drugs is assessed by therapeutic indication and innovative delivery technologies are discussed at length and benchmarked against one another. rbdl0004

Scope of this research

* Discover which companies led the transdermal drug market in 2009 and analyze the performance of their leading products.
* Analyze the leading drug classes which are delivered transdermally with insights into their pipelines and future prospects.
* Evaluate emerging technologies in transdermal drug delivery and assess which have the greatest chances of success.
* Understand the impact that new technologies can have on the market and which new indications are best suited to transdermal treatment.
* Discover why certain technologies have been commercial failures in specific indications.

Research and analysis highlights

The market for drugs delivered transdermally was valued at $5.6bn in with the US market being the largest individual market. The transdermal drug market is growing more slowly than the overall pharmaceutical market indicating a level of maturity and a lack of new approved products. New technologies may change this dynamic.

Novartis was the leading company in the global transdermal drug market in 2009 with a market share of over 20%. Novartis' position was driven by both branded products such as Exelon patch and generics from its Sandoz subsidiary. Sandoz markets generic fentanyl, scopolamine, and nicotine patches.

Innovative technologies that allow for the transdermal delivery of drugs that currently not be delivered in this way are poised to revolutionize the market. These include chemical penetration enhancers, iontophoresis, dermal ablation and microneedles amongst others. Several new lucrative indications may be opened up to transdermal drug delivery.

Key reasons to purchase this research

* Which companies lead the transdermal drug delivery market and what are their key transdermal products?
* Which indications drive the transdermal drug market and what are the leading transdermal products within these markets?
* How has the introduction of Exelon Patch impacted upon the sales of oral formulations of Exelon?
* Which technologies are being developed to allow the transdermal delivery of a wider variety of drug types and what will their impact be?
* Which indications not currently served by transdermally delivered drugs have the greatest potential for treatment improvement by transdermal drugs?

For more information or to purchase this report, go to:
-  http://www.fastmr.com/prod/96338_advances_in_the_transder...

Partial Table of Contents:

Table of Contents
Disclaimer 2
Executive summary 8
Market overview 8
Leading players 9
Technological innovations in transdermal drug delivery 10
Chapter 1 Market overview 11
Summary 11
Introduction 12
Geographic distribution of sales 12
Therapeutic focus 15
Narcotic analgesics 16
Fentanyl 17
Buprenorphine 21
Developmental products 23
Outlook 27
Antihypertensives 28
Nitroglycerin 29
Clonidine 31
Isosorbide dinitrate 33
Developmental products 33
Outlook 33
Alzheimer's disease 34
Developmental products 34
Outlook 36
Hormone replacement in women 36
Developmental products 39
Outlook 40
Smoking cessation 41
Developmental products 43
Outlook 43
Chapter 2 - Leading players 44
Summary 44
Market analysis 45
Leading players 45
Novartis 47
Johnson & Johnson 53
Mylan 58
Watson 61
Boehringer Ingelheim 66
Trends in generic usage 67
Chapter 3 - Technological innovation in transdermal drug delivery 69
Summary 69
Introduction 70
Advantages of transdermal drug delivery 70
First generation transdermal delivery systems 71
Typical designs of first generation transdermal delivery systems 72
Examples of marketed first generation transdermal drugs 73
Transderm Scop 73
Sancuso 73
Second generation transdermal delivery systems 74
Technologies used in second generation systems 75
Chemical penetration enhancers 75
Encapsulation 76
Iontophoresis 78
Noncavitational ultrasound 80
Third generation transdermal delivery systems 81
Technologies used in third generation systems 81
Synergistic combinations of penetration enhancers 81
Biochemical penetration enhancers 81
Electroporation 82
Cavitational ultrasound 83
Dermal ablation/poration 84
Microneedles 87
The future outlook for transdermal delivery 89
Appendix 94
Primary Research Methodology 94
Glossary 95
Bibliography 96
Table of figures
Figure 1: Transdermal market in the 7MM, market share 2009 14
Figure 2: Transdermal market in the BRIC countries, market share 2009 14
Figure 3: Breakdown of the transdermal narcotic analgesics market by molecule, $m, 2009 17
Figure 4: Breakdown of the fentanyl market 2005-2009 19
Figure 5: Comparison of fentanyl patch formulations 20

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=9633...

About Business Insights

Business Insights appreciate the importance of accurate, up-to-date incisive market and company analysis and their aim therefore is to provide a single, off-the-shelf, objective source of data, analysis and market insight. Business Insights work in association with leading industry experts to produce a range of reports across a wide range of industry sectors.  By working in association with so many experts they are able to provide clients with more incisive market analysis specific to the client's industry sector. No other market analysis company provides such focused and trusted market analysis, across such a wide range of industry sectors.  View more research from Business Insights at http://www.fastmr.com/catalog/publishers.aspx?pubid=1003

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

# # #

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.